Key result
In conscious rats, NOS inhibition with L-NAME accelerated the pressor response to low-dose Angiotensin II, induced renin escape, and exacerbated renal and cardiac target organ damage.
Why the study?
Does nitric oxide synthase inhibition with L-NAME accelerate the pressor response and exacerbate target organ damage from low-dose angiotensin II in conscious rats?
Does nitric oxide synthase inhibition with L-NAME accelerate the pressor response and exacerbate target organ damage from low-dose angiotensin II in conscious rats?
Nitric oxide synthase inhibition accelerates angiotensin II-induced hypertension and exacerbates renal and cardiac target organ damage in a rat model, highlighting the protective role of endogenous nitric oxide.
NOS inhibition hastens Ang II effects in rats; leaves open relevance to human hypertension progression.
Because nitric oxide may attenuate both the pressor and cytotoxic effects of angiotensin II (Ang II), we investigated whether nitric oxide synthase (NOS) inhibition might accelerate the slow pressor effect of Ang II, and augment target organ damage. Using conscious, chronically catheterized rats, we previously observed that low-dose Ang II (10 ng/kg/min) rapidly increased mean arterial pressure (MAP) by approximately 25 mm Hg. The MAP then remained at this level for 2 to 4 days, and then increased again during the next 5 days by a further 25 mm Hg to a second plateau. In the present study, 7 days of N(omega)-nitro-l-arginine methyl ester (L-NAME; 10 microg/kg/min) alone increased MAP by 16 mm Hg. When Ang II was added to L-NAME, MAP increased as much as with Ang II alone, but then continued to increase until day 4, reaching a plateau as high as that reached only on day 9 of Ang II alone. In approximately half the rats infused with L-NAME + Ang II, plasma renin escaped from Ang II-induced suppression after day 4 of Ang II, and continued to increase for the duration of the study. On the first day that Ang II was added to L-NAME, urinary protein excretion and plasma cardiac troponin T increased, indicating early target organ damage. By the end of the study, all rats treated with L-NAME + Ang II developed tubulointerstitial and glomerular injuries, fibrosis of the renal and cardiac arteries, and cardiac interstitial fibrosis. Target organ damage was greater in rats that developed renin escape than in those in which plasma renin remained suppressed, but was minimal in rats infused with Ang II or L-NAME alone. Taken together, these findings suggest that endogenous NO normally attenuates the pressor response to low-dose Ang II for several days, and protects from Ang II-induced target organ damage. Under conditions of reduced NO bioavailability, which may result from endothelial insufficiency, relatively small changes in circulating Ang II levels may damage target organs. Moreover, renal damage leading to renin escape may initiate a vicious cycle of elevated Ang II production, leading to higher blood pressure and greater target organ damage.
No takes yet. Share an insight, caveat, or question.
Li Hu (2004) studied Hypertension. N(omega)-nitro-l-arginine methyl ester (L-NAME) and Angiotensin II vs. Angiotensin II alone or L-NAME alone was evaluated on Mean arterial pressure (MAP) and target organ damage. In conscious rats, NOS inhibition with L-NAME accelerated the pressor response to low-dose Angiotensin II, induced renin escape, and exacerbated renal and cardiac target organ damage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: